New drug combo shows promise against tough cervical cancer
Disease control
Ongoing
This study tests whether combining two drugs, dostarlimab and cobolimab, can shrink tumors or slow the disease in people with advanced or recurrent cervical cancer. About 66 participants with measurable tumors will receive the combination. The main goal is to see how many patient…
Phase: PHASE2 • Sponsor: Meghan Shea • Aim: Disease control
Last updated May 18, 2026 12:11 UTC